Salvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancer

被引:18
|
作者
Verstegen, Naomi E. [1 ]
Maat, Alexander P. W. M. [2 ]
Lagerwaard, Frank J. [1 ]
Paul, Marinus A. [3 ]
Versteegh, Michel I. [4 ]
Joosten, Joris J. [5 ]
Lastdrager, Willem [6 ]
Smit, Egbert F. [7 ]
Slotman, Ben J. [1 ]
Nuyttens, Joost J. M. E. [8 ]
Senan, Suresh [1 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr Amsterdam, Dept Radiat Oncol, De Boelelaan 1117,Postbox 7057, NL-1007 MB Amsterdam, Netherlands
[2] Erasmus MC, Dept Cardiothorac Surg, Rotterdam, Netherlands
[3] Vrije Univ Amsterdam, Dept Cardiothorac Surg, Med Ctr Amsterdam, Amsterdam, Netherlands
[4] Leiden Univ, Dept Cardiothorac Surg, Med Ctr, Leiden, Netherlands
[5] Westfriesgasthuis Hoorn, Dept Surg, Hoorn, Netherlands
[6] Gelre Hosp Apeldoorn, Dept Surg, Apeldoorn, Netherlands
[7] Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands
[8] Erasmus MC, Dept Radiat Oncol, Rotterdam, Netherlands
来源
RADIATION ONCOLOGY | 2016年 / 11卷
关键词
BODY RADIOTHERAPY; FOLLOW-UP; SURGICAL COMPLICATIONS; CT SCANS; RECURRENCE; OUTCOMES; CLASSIFICATION; MANAGEMENT; DIAGNOSIS; PATTERNS;
D O I
10.1186/s13014-016-0706-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: The literature on surgical salvage, i.e. lung resections in patients who develop a local recurrence following stereotactic ablative radiotherapy (SABR), is limited. We describe our experience with salvage surgery in nine patients who developed a local recurrence following SABR for early stage non-small cell lung cancer (NSCLC). Methods: Patients who underwent surgical salvage for a local recurrence following SABR for NSCLC were identified from two Dutch institutional databases. Complications were scored using the Dindo-Clavien-classification. Results: Nine patients who underwent surgery for a local recurrence were identified. Median time to local recurrence was 22 months. Recurrences were diagnosed with CT- and/or 18FDG-PET-imaging, with four patients also having a pre-surgical pathological diagnosis. Extensive adhesions were observed during two resections, requiring conversion from a thoracoscopic procedure to thoracotomy during one of these procedures. Three patients experienced complications post-surgery; grade 2 (N = 2) and grade 3a (N = 1), respectively. All resection specimens showed viable tumor cells. Median length of hospital stay was 8 days (range 5-15 days) and 30-day mortality was 0 %. Lymph node dissection revealed mediastinal metastases in 3 patients, all of whom received adjuvant therapy. Conclusions: Our experience with nine surgical procedures for local recurrences post-SABR revealed two grade IIIa complications, and a 30-day mortality of 0 %, suggesting that salvage surgery can be safely performed after SABR.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Audit of radiotherapy plan quality for stereotactic ablative radiotherapy (SABR) for stage 1 non-small cell lung cancer
    Pascoe, A. C.
    Foweraker, K.
    Esler, C.
    Morgan, S.
    Wallace, A.
    Launders, D.
    Harron, E.
    CLINICAL ONCOLOGY, 2016, 28 : S4 - S4
  • [42] Worldwide Utilization of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Are We All in Sync?
    Alfaifi, S.
    Louie, A. V.
    Siva, S.
    Guckenberger, M.
    Videtic, G. M.
    Higgins, K.
    Alshafa, F.
    AlGhamdi, H.
    Gillespie, E. F.
    Stephans, K. L.
    Mula-Hussain, L.
    Harrow, S.
    Palma, D. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E1 - E2
  • [43] Stereotactic ablative radiotherapy in treatment of early-stage non-small cell lung cancer: Unsolved questions and frontiers ahead
    Zhang, Jingze
    Kong, Li
    Jiao, Qinghua
    Li, Minghuan
    Yu, Jingming
    CANCER LETTERS, 2017, 401 : 46 - 52
  • [44] Stereotactic ablative radiotherapy in combination with nivolumab for early stage operable non-small cell lung cancer: A phase II study
    Schvartsman, G.
    Amarato, Y.
    dos Santos, G. Prado
    Gomes, D. Bugano Diniz
    Koch, L. D. O.
    Bibas, B.
    Gomes, O., Jr.
    Campregher, P. Vidal
    Severino, P.
    Marti, L. Cavalheiro
    Ribeiro, V. Paes
    Leaden, L.
    Chate, R. Caruso
    de Campos, J. Ribas Milanez
    Sousa, V. A. Ramos
    Taranto, P.
    Moura, F. S.
    Terra, R. M.
    Rezende, A. C. P. D.
    Samano, M. Naoyuki
    ANNALS OF ONCOLOGY, 2024, 35 : S785 - S785
  • [45] The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing Paradigms
    Dahele, Max
    Senan, Suresh
    CANCER RESEARCH AND TREATMENT, 2011, 43 (02): : 75 - 82
  • [46] SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS ON STEREOTACTIC ABLATIVE RADIOTHERAPY FOR THE TREATMENT OF EARLY-STAGE NON-SMALL CELL LUNG CANCER
    Maia, De Albuquerque F.
    Rozman, L.
    Carvalho, De Andrade H.
    De Soarez, P. C.
    VALUE IN HEALTH, 2022, 25 (01) : S48 - S48
  • [47] Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: A critical literature review of predictive factors of relapse
    Loganadane, Gokoulakrichenane
    Martinetti, Florent
    Mercier, Olaf
    Krhili, Samar
    Riet, Francois-Georges
    Mbagui, Rodrigue
    To, Hanh
    Le Pechoux, Cecile
    Levy, Antonin
    CANCER TREATMENT REVIEWS, 2016, 50 : 240 - 246
  • [48] Stereotactic Ablative Radiotherapy with Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer: a phase 2 study
    Beal, J.
    Gomes, D.
    Taranto, P.
    Koch, L.
    Rezende, A. C.
    Samano, M.
    Bibas, B.
    Gomes, O.
    Campregher, P.
    Severino, P.
    Marti, L.
    Paes, V.
    Chate, R.
    Sales, D.
    Schvartsman, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S651 - S652
  • [49] Great debate: surgery versus stereotactic radiotherapy for early-stage non-small cell lung cancer
    Hiley, Crispin
    Salem, Ahmed
    Batchelor, Tim
    McDonald, Fiona
    Evison, Matthew
    THORAX, 2020, 75 (03) : 198 - 199
  • [50] STEREOTACTIC BODY ABLATIVE RADIOTHERAPY FOR STAGE I NON SMALL CELL LUNG CANCER
    Beltramo, G.
    Bergantin, A.
    Martinotti, A.
    Bonfanti, P.
    Bianchi, L. C.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S570 - S571